Therapeutic Approaches for Duchenne Muscular Dystrophy: Old and New.
Semin Pediatr Neurol
; 37: 100877, 2021 04.
Article
em En
| MEDLINE
| ID: mdl-33892842
ABSTRACT
Duchenne muscular dystrophy (DMD) is marked by pathogenic variants in the DMD gene, leading to reduced or absent dystrophin translation, muscle fiber destruction, loss of ambulation, cardiomyopathy, respiratory failure, and eventually death. Disease progression is slowed with use of prednisone or other corticosteroid agents. Gene replacement therapy, which is one of the focus points of this review, has emerged as the most promising potential treatment for DMD, though alternative RNA-based strategies have been employed for patients with specific pathogenic variants. While challenges remain, many of these novel therapeutic approaches hold promise for treating this devastating disease.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Distrofia Muscular de Duchenne
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article